IBSP anticorps

N° du produit ABIN630260

Détail du produit anti-IBSP anticorps

Antigène: IBSP (Integrin-Binding Sialoprotein (IBSP))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp IBSP est non-conjugé

Application: Western Blotting (WB)

Purification: Purified

Immunogène: IBSP antibody was raised using a synthetic peptide corresponding to a region with amino acids SATTLGYGEDATPGTGYTGLAAIQLPKKAGDITNKATKEKESDEEEEEEE

Information d'application

Indications d'application: WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

IBSP Blocking Peptide, catalog no. 33R-8321, is also available for use as a blocking control in assays to test for specificity of this IBSP antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Reconstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of IBSP antibody in PBS

Concentration: Lot specific

Buffer: PBS

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Détails sur IBSP

Antigène: IBSP (Integrin-Binding Sialoprotein (IBSP))

Autre désignation: IBSP (IBSP Produits)

Synonymes: anticorps BNSP, anticorps BSP, anticorps BSP-II, anticorps SP-II, anticorps Bsp, anticorps BSP II, anticorps BSPII, anticorps Bsp2, anticorps IBSP, anticorps integrin binding sialoprotein, anticorps integrin-binding sialoprotein, anticorps integrin-binding sialoprotein S homeolog, anticorps IBSP, anticorps Ibsp, anticorps ibsp.S, anticorps ibsp

Sujet: The protein encoded by the IBSP gene is a major structural protein of the bone matrix. It constitutes approximately 12% of the noncollagenous proteins in human bone and is synthesized by skeletal-associated cell types, including hypertrophic chondrocytes, osteoblasts, osteocytes, and osteoclasts. The only extraskeletal site of its synthesis is the trophoblast. This protein binds to calcium and hydroxyapatite via its acidic amino acid clusters, and mediates cell attachment through an RGD sequence that recognises the vitronectin receptor.

Poids moléculaire: 35 kDa (MW of target protein)